Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancer subtypes, largely due to heterogeneity and lack of treatment options. Due to absence of targetable hormone receptor expression, chemotherapy is the current standard of care for TNBC. However, recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Newton, Emma E., Mueller, Lauren E., Treadwell, Scout M., Morris, Cindy A., Machado, Heather L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833442/
https://www.ncbi.nlm.nih.gov/pubmed/35158750
http://dx.doi.org/10.3390/cancers14030482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833442/
https://www.ncbi.nlm.nih.gov/pubmed/35158750
http://dx.doi.org/10.3390/cancers14030482

Ejemplares similares